TABLE 1—
Variable | White, No. (%) or Mean ±SD | Black, No. (%) or Mean ±SD | Hispanics, No. (%) or Mean ±SD | Other, No. (%) or Mean ±SD | P |
Total | 457 (14.0) | 2367 (72.6) | 346 (10.6) | 89 (2.7) | |
Maternal age, y | 26.4 ±5.7 | 26.4 ±5.9 | 26.3 ±5.7 | 26.8 ±6.3 | .94 |
Metro indexa | |||||
Large metro | 188 (41.1) | 1238 (52.3) | 195 (56.4) | 41 (46.1) | <.01 |
Small metro | 169 (37.0) | 714 (30.2) | 95 (27.5) | 30 (33.7) | |
Nonmetro | 100 (21.9) | 415 (17.5) | 56 (16.2) | 18 (20.2) | |
AIDS conditions | 21 (4.6) | 120 (5.1) | 9 (2.6) | 5 (5.6) | .24 |
Comorbidity | 199 (43.5) | 886 (37.4) | 110 (31.8) | 36 (40.5) | <.01 |
Cesarean delivery | 245 (53.6) | 1349 (57.0) | 184 (53.2) | 46 (51.7) | .28 |
Mos enrolled in Medicaidb | 21.2 ±10.7 | 22.9 ±10.8 | 8.6 ±9.9 | 15.1 ±12.5 | <.01 |
Enrolled in Medicaid < 3 mob | 18 (3.9) | 74 (3.1) | 151 (43.6) | 17 (19.1) | <.01 |
Treatment | |||||
HAARTc | 228 (49.9) | 888 (37.5) | 51 (14.7) | 23 (25.8) | <.01 |
Suboptimal treatmentd | 95 (20.8) | 701 (29.6) | 41 (11.9) | 18 (20.2) | |
No ARV | 134 (29.3) | 778 (32.9) | 254 (73.4) | 48 (53.9) |
Note. ARV = antiretroviral therapy; HAART = highly active antiretroviral therapy.
Large metro = metropolitan area with 1 million residents or more; small metro = metropolitan area with fewer than 1 million residents; nonmetro = rural area.
Eligible months over 3 years of Medicaid claim data.
HAART included at least 1 nucleoside reverse-transcriptase inhibitor and at least 2 other agents.
Suboptimal treatment = some or any ARV treatment prescription other than HAART.